ELLINGTON MANAGEMENT GROUP LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 111 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.

Quarter-by-quarter ownership
ELLINGTON MANAGEMENT GROUP LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$403,000
+32.6%
26,000
+67.7%
0.07%
+231.8%
Q1 2018$304,000
-65.7%
15,500
-77.3%
0.02%
-26.7%
Q1 2017$886,000
+14.0%
68,400
+6.4%
0.03%
-86.0%
Q3 2016$777,000
+447.2%
64,300
+328.7%
0.21%
+250.8%
Q1 2016$142,000
-35.7%
15,000
-8.9%
0.06%
-1.6%
Q3 2015$221,000
+87.3%
16,472
+35.0%
0.06%
+59.0%
Q4 2014$118,000
-13.9%
12,200
-12.2%
0.04%
-39.1%
Q2 2014$137,000
-63.0%
13,900
-58.5%
0.06%
-8.6%
Q3 2013$370,00033,5000.07%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Third Security, LLC 1,129,551$51,293,0007.24%
First Light Asset Management, LLC 2,050,273$93,103,0005.59%
TRAN CAPITAL MANAGEMENT, L.P. 1,350,870$61,343,0005.06%
SNYDER CAPITAL MANAGEMENT L P 3,176,404$144,241,0004.04%
DOHENY ASSET MANAGEMENT /CA 91,930$4,175,0002.69%
Redwood Investments, LLC 538,656$24,460,0001.97%
HighMark Wealth Management LLC 53,457$2,427,0001.78%
Taylor Wealth Management Partners 85,409$3,878,0001.37%
SILVERARC CAPITAL MANAGEMENT, LLC 66,673$3,028,0001.35%
Granite Investment Partners, LLC 919,029$41,733,0001.29%
View complete list of HALOZYME THERAPEUTICS INC shareholders